β οΈ Important safety: Fluoroquinolones (including ciprofloxacin) carry risks of tendon rupture, neuropsychiatric effects, QT prolongation, and (rarely) aortic aneurysm/dissection.
Use is restricted in UK practice β reserve for situations where other agents are inappropriate.
π About
- Ciprofloxacin is a fluoroquinolone antibiotic with broad Gram-negative activity, including Pseudomonas aeruginosa.
- Inhibits cytochrome P450 (CYP1A2), leading to multiple drug interactions.
- Well absorbed orally; widely distributed; primarily excreted renally.
- Always check the BNF for the latest guidance.
βοΈ Mode of Action
- Bactericidal: inhibits DNA gyrase (topoisomerase II) and topoisomerase IV.
- This prevents DNA replication, transcription, and repair in bacteria.
π¦ Activity Spectrum
- Gram negatives: E. coli, Klebsiella, Enterobacter, Salmonella, Shigella, Neisseria, Campylobacter, Haemophilus, Pseudomonas.
- Gram positives: limited (Staphylococcus aureus, Enterococcus faecalis); poor pneumococcal activity (not reliable for community pneumonia).
- Atypicals: some activity against Chlamydia and Mycoplasma, but not first-line.
π©Ί Indications & Dose (BNF β check locally)
- Severe Gram-negative infections including Pseudomonas (esp. in cystic fibrosis).
- Complicated UTI / prostatitis.
- Typhoid and paratyphoid fever.
- Travellerβs diarrhoea.
- Anthrax (inhalation exposure).
- Gonorrhoea (not reliable due to resistance).
- Typical doses:
- Oral: 500β750 mg every 12 hours.
- IV: 400 mg every 12 hours, infused over 30β60 minutes.
π« Contraindications
- History of tendon disorders with fluoroquinolone use.
- Pregnancy and breastfeeding (avoid unless essential).
- Children and adolescents (avoid except in cystic fibrosis or life-threatening infections).
- Concomitant use with tizanidine (contraindicated β risk of severe hypotension).
β οΈ Cautions
- Epilepsy or CNS disorders (lowers seizure threshold).
- History of psychiatric illness (risk of agitation, psychosis).
- Myasthenia gravis (may exacerbate weakness).
- Cardiac disease / electrolyte abnormalities (risk of QT prolongation).
- Concurrent corticosteroid use (β risk of tendon rupture).
β Side Effects
- GI upset: nausea, vomiting, diarrhoea.
- CNS: insomnia, dizziness, confusion, hallucinations, seizures.
- Musculoskeletal: tendonitis, tendon rupture (esp. Achilles).
- CVS: QT prolongation, arrhythmias, rare aortic aneurysm/dissection.
- Hepatic: hepatitis, abnormal LFTs.
- Photosensitivity.
π Interactions
- Warfarin: potentiates anticoagulant effect β β INR.
- Theophylline: β risk of toxicity (CYP1A2 inhibition).
- Caffeine: reduced clearance β β stimulant effects.
- Antacids / iron / calcium: reduce ciprofloxacin absorption (separate by β₯2 hrs).
- Probenecid: reduces renal excretion of ciprofloxacin.
- Tizanidine: contraindicated (severe hypotension, sedation).
π References